Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objectives</h3>Hyperactivity of T lymphocytes might play an important role in the pathogenesis of primary Sjögren's syndrome (pSS). CD226/T cell immunoglobulin and ITIM domain (TIGIT) pathway is a newly identified immune checkpoint involved in the pathogenesis of cancer and rheumatic diseases. However, its role in the pathophysiology of pSS is obscure. Hence, this study aimed to explore the potential role of CD226/TIGIT expression on T cells in the pathogenesis of pSS.<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3>In patients with pSS, other rheumatic disease controls (DCs), and healthy controls (HCs), the expression of CD226 and TIGIT on T cells along with their activity following stimulation were detected by flow cytometry. The correlations between the expression of CD226 and TIGIT on T cells and clinical data were analyzed.<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3>The frequencies of CD226/TIGIT expressing CD4+ and CD8+ T cells were significantly higher in patients with pSS than in HCs and DCs. Among them, the TIGIT/CD226 expressing CD4+ T cells closely correlated with pSS disease activity: the percentages of CD4+CD226+ and CD4+TIGIT+ T cells were significantly higher in the active pSS than the inactive pSS. The proportion of CD4+TIGIT+ T cells positively correlated with the erythrocyte sedimentation rate. Further in vitro analysis revealed that CD4+CD226+ T cells exerted superior effector function than the CD226- counterparts in both pSS and HCs. TIGIT was preferably expressed on activated cells, and the activity of CD4+TIGIT+ T cells was comparable with CD4+TIGIT− T cells in HCs. However, in pSS, CD4+TIGIT+ T cells showed enhanced activity than the CD4+ TIGIT− T cells.<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3>CD226/TIGIT checkpoint molecules were over-expressed on T cells in pSS. Proportional and functional alteration of CD226/TIGIT expressing CD4+ T cells may be involved in the pathogenesis of pSS, and be a potential novel therapeutic target for the disease.

Immune skew of follicular helper T cells and effector T cells in patients with Sjögren's syndrome

Follicular Helper T Cells and Follicular Regulatory T Cells in the Immunopathology of Primary Sjögren's Syndrome

Follicular helper T cells and follicular regulatory T cells in the immunopathology of primary Sjogren's syndrome

Advances in the Pathogenesis and Treatment of Primary Sj(o)gren's Syndrome

Tph Cells Expanded in Primary Sjögren’s Syndrome

Effect of Chinese Herbal Medicines for Nourishing Yin, Supplementing Qi, and Activating Blood on Reproductive Endocrine Activity and Immune Functions in Patients with Primary Sjogren's Syndrome.

Elevated Level of Circulating CD4+Helios+FoxP3+ Cells in Primary Sjogren's Syndrome Patients.

Unraveling the transcriptome-based network of tfh cells in primary sjogren syndrome: insights from a systems biology approach

Single-Cell RNA Sequencing Reveals the Expansion of Cytotoxic CD4+ T Lymphocytes and a Landscape of Immune Cells in Primary Sjögren’s Syndrome

Single-cell transcriptome profiling reveals immune and stromal cell heterogeneity in primary Sjögren’s syndrome

The Multiple Roles of B Cells in the Pathogenesis of Sjögren’s Syndrome

Single-cell transcriptomic analysis uncovers heterogeneity in the labial gland microenvironment of primary Sjögren's syndrome

Subpopulation dynamics of T and B lymphocytes in Sjögren's syndrome: implications for disease activity and treatment

Comparison of the deep immune profiling of B cell subsets between healthy adults and Sjogren's syndrome

Expression of FcγRⅡb on peripheral B cells and its clinical significance in patients with primary Sj(o)gren's syndrome

Alteration of CD226/TIGIT immune checkpoint on T cells in the pathogenesis of primary Sjögren's syndrome

Patients with Early-Onset Primary Sjögren’s Syndrome Have Distinctive Clinical Manifestations and Circulating Lymphocyte Profiles

The Clinical Relevance of IL-17-Producing CD4+CD161+ Cell and Its Subpopulations in Primary Sjögren's Syndrome

Comparison of the deep immune profiling of B cell subsets between healthy adults and Sjögren’s syndrome

Detection of T Follicular Helper Cells and T Follicular Regulatory Cells in Experimental Sjögren's Syndrome.

Immunobiology of T Cells in Sjögren’s Syndrome